Eli Lilly & Co. v. Home Insurance Co.

482 N.E.2d 467, 1985 Ind. LEXIS 953
CourtIndiana Supreme Court
DecidedSeptember 12, 1985
Docket685S243
StatusPublished
Cited by172 cases

This text of 482 N.E.2d 467 (Eli Lilly & Co. v. Home Insurance Co.) is published on Counsel Stack Legal Research, covering Indiana Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Eli Lilly & Co. v. Home Insurance Co., 482 N.E.2d 467, 1985 Ind. LEXIS 953 (Ind. 1985).

Opinion

GIVAN, Chief Justice.

This cause comes before this Court on the certification of three questions of state law by the United States Court of Appeals for the District of Columbia Circuit Eli Lilly and Co. v. Home Insurance Co. (D.C.Cir.1985), 764 F.2d 876. This Court has jurisdiction to answer the certified questions. Ind.R.App.P. 15(0).

On March 9, 1982, Eli Lilly and Company filed this declaratory judgment action in the United States District Court for the District of Columbia. Named as defendants were the various insurance companies that insured Lilly from 1947, when Lilly first manufactured and sold the drug die-thylstilbestrol (DES), to 1976, when the insurers refused to insure DES risks. The suit involves the seope of products liability insurance coverage for claims arising from DES-related illnesses. Id. at 878. The basic dispute concerns what must happen during a particular policy period to invoke insurance coverage for that period, described by the insurers as the trigger of coverage.

From the late 1940's until 1971, DES was prescribed to pregnant women for the purpose of preventing spontaneous miscarriages. In 1970, researchers reported a significant statistical connection between ingestion of DES by pregnant women and the later development of vaginal clear-cell ade-nocarcinoma, vaginal adenosis and other reproductive tract disorders in daughters of DES users who were in utero at the time of the DES ingestion.

For a twenty-year period commencing in 1947, Lilly was one of the major manufacturers and sellers of DES. Lawsuits arising from DES-related illnesses began in 1972. At the time Lilly filed for summary judgment in this action, approximately 650 lawsuits had been filed against Lilly, and additional suits have since been filed.

On April 12, 1984, the District Court, in a memorandum opinion, granted Lilly's motion for summary judgment. The court determined that a conflict of laws existed and that Indiana law should govern. The court also determined that under Indiana law the extrinsic evidence offered by the insurers was not relevant in construing the *469 insurance contracts. The court also held that the Indiana courts would follow Keene Corp. v. Insurance Co. of North America (D.C.Cir.1981), 667 F.2d 1034, cert. denied (1982), 455 U.S. 1007, 102 S.Ct. 1644, 71 L.Ed.2d 875, and adopt a multiple trigger interpretation of the insurance contracts. Under the Keene approach, originally applied in the context of asbestos-related illnesses, each insurer on the risk at any time between the initial ingestion of DES and the subsequent manifestation of a DES-related illness would be liable to Lilly for indemnification. See Id. at 1041.

The insurers appealed that decision. While agreeing that Indiana law controls, the Court of Appeals found themselves "uncertain about the application of that law to the issues at hand," Eli Lilly, supra at 878, and certified the following questions to this Court:

"1. -Under Indiana insurance contract law, should the types of extrinsic evidence proffered by the insurers be considered in the interpretation of the disputed 'trigger' provisions?
"2, If any aspect of the insurers' extrinsic evidence should be considered, would Indiana courts require a determination of the parties' actual intent concerning the application of the 'trigger' provision to delayed manifestation injuries? Or would Indiana courts permit a determination, after consideration of the extrinsic evidence, that the parties did not hold or convey a clear understanding of the trigger provision's applicability to delayed manifestation injuries and that, thus, the provision must be interpreted by the court as a matter of Indiana insurance law?
"8. If the insurers' extrinsic evidence should not be considered, or if that evidence is not determinative of the parties' intent, how should the insurance policy provision at issue be interpreted under Indiana law? In other words, would Indiana courts adopt an exposure, a manifestation, a multiple trigger, or some other interpretation of the 'injury'/'oecurrence' language in Eli Lilly's policies?" Id. at 884-85.

The insurance policies at issue are "manuscript" policies written specifically for Lilly, The provision in each of the policies providing for liability coverage is, however, identical in all material respects to the coverage provision in the insurance industry's Comprehensive General Liability Policy (CGL). The CGL is a standard form policy for liability coverage adopted by the insurance industry in the 1960's to address the problem of insidious diseases which manifest after initial exposure to the substance believed to cause them.

The relevant clause in the majority of Lilly's policies defined coverage in terms of an "injury" that "occurs" during the policy period. Specifically, those policies provided that:

"[uJnderwriters hereby agree, subject to the limitations, terms and conditions hereafter mentioned, to indemnify the Assured for all sums which the Assured shall be obligated to pay ... for damages, direct or consequential, and expenses, all as more fully defined by the term 'ultimate net loss," on account of
"(i) personal injuries, including death at any time resulting therefrom, caused by or arising out of each occurrence anywhere in the world."

Thus the majority of Lilly's policies did not definitely state when an injury occurs in cases of insidious diseases. The parties do not contend that the relevant language in the remaining policies is significantly different.

As noted by the Court of Appeals, the policies did not define the relevant terms with precision. Eli Lilly, supra at 879. "Personal injury" was defined in part as "bodily injury, mental injury, mental anguish." "Occurrence" was defined as "an accident or a happening or event or a continuous or repeated exposure to conditions which unexpectedly and unintentionally results in personal injury ... during the policy period." The Court of Appeals has defined its task to be interpreting those terms with respect to claims arising from DES-related illnesses, the determinative question *470 being when the DES-related "injury" "occurs" for purposes of the policies. Id. at 879-80.

The first question is whether under Indiana law the insurers' extrinsic evidence should be used to interpret Lilly's policies. The District Court determined that the evidence was not necessary to its construction of the policy language. The court determined that in cases where the contract is one for insurance, Indiana courts will employ the basic principles governing the interpretation of insurance policies to give effect to the parties' reasonable expectations rather than conduct a searching inquiry into extrinsic evidence.

The insurers dispute the District Court's interpretation and argue that, under Indiana contract and insurance law, their proffered evidence should be considered. They contend the extrinsic evidence "is relevant to (1) the parties' intent in adopting the policies, (2) the parties' course of conduct in applying the policies, (8) Eli Lilly's sophistication and strength as a bargaining partner, and (4) the medical nature of DES-related illnesses." Id. at 881.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

American Family Mutual Insurance v. Williams
135 F. Supp. 3d 834 (S.D. Indiana, 2015)
Pekin Insurance Company v. Jose and Carol Hanquier and Joseph Hall
984 N.E.2d 227 (Indiana Court of Appeals, 2013)
State Farm Mutual Automobile Insurance v. Sellers
854 F. Supp. 2d 609 (N.D. Indiana, 2012)
Wellpoint, Inc. v. National Union Fire Insurance Co.
952 N.E.2d 254 (Indiana Court of Appeals, 2011)
French v. State Farm Fire & Casualty Co.
950 N.E.2d 303 (Indiana Court of Appeals, 2011)
State Automobile Mutual Insurance Co. v. Flexdar, Inc.
937 N.E.2d 1203 (Indiana Court of Appeals, 2010)
Ashby v. Davidson
930 N.E.2d 53 (Indiana Court of Appeals, 2010)
McGrath v. Everest National Insurance
668 F. Supp. 2d 1085 (N.D. Indiana, 2010)
Indiana Farmers Mutual Insurance Co. v. North Vernon Drop Forge, Inc.
917 N.E.2d 1258 (Indiana Court of Appeals, 2009)
BKCAP, LLC v. CAPTEC Franchise Trust 2000-1
572 F.3d 353 (Seventh Circuit, 2009)
Dean Officer v. Chase Insurance Life & Annuity
478 F. Supp. 2d 1069 (N.D. Indiana, 2007)
Empire Fire & Marine Insurance v. Sargent
211 F. App'x 506 (Seventh Circuit, 2007)
Eli Lilly and Co. v. Zurich American Ins. Co.
405 F. Supp. 2d 948 (S.D. Indiana, 2005)
Allstate Insurance Co. v. Burns
837 N.E.2d 645 (Indiana Court of Appeals, 2005)
Wolf Lake Terminals, Inc. v. Mutual Marine Insurance
433 F. Supp. 2d 933 (N.D. Indiana, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
482 N.E.2d 467, 1985 Ind. LEXIS 953, Counsel Stack Legal Research, https://law.counselstack.com/opinion/eli-lilly-co-v-home-insurance-co-ind-1985.